Paper Details

  1. Home
  2. Paper Details

Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.

Author: , Abraham-NordlingMirna, AnderssonTommy, AsmanPeter, BergGertrud, CalissendorffJan, HallengrenBengt, HednerPavo, LantzMikael, LundellGöran, NyströmErnst, PonjavicVesna, TallstedtLeif, TaubeAdam, TräiskFrank, TörringOve, WallinGöran

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Radioiodine treatment is a significant risk factor for the development of thyroid-associated ophthalmopathy (TAO) in Graves' hyperthyroidism. The risk of developing TAO was greater in patients treated with iodine-131 than with medical treatment.
Paper Details　
Original Abstract of the Article :
CONTEXT: Previous randomized trials have suggested an association between radioiodine treatment for Graves' hyperthyroidism and thyroid-associated ophthalmopathy (TAO). OBJECTIVES: The aim of the study was to compare the occurrence of worsening or development of TAO in patients who were treated wit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1210/jc.2009-0747

データ提供：米国国立医学図書館（NLM）

Thyroid-Associated Ophthalmopathy: Understanding the Risk Factors Associated with Treatment for Graves' Hyperthyroidism

Graves' hyperthyroidism, a condition affecting the thyroid gland, can be like a desert wind, causing a whirlwind of symptoms. Treatment options for Graves' hyperthyroidism include antithyroid drugs and radioactive iodine (I-131). This study, like a meticulous investigation of a desert's ecosystem, explores the potential risks of each treatment option regarding thyroid-associated ophthalmopathy (TAO), a condition that can cause eye problems. The researchers, like skilled ecologists, conducted a randomized trial to compare the occurrence of TAO in patients treated with I-131 or antithyroid drugs.

Radioiodine Treatment: A Potential Risk Factor for Thyroid-Associated Ophthalmopathy

The study's findings, like a warning sign in a desert landscape, reveal that radioiodine treatment is a significant risk factor for the development of TAO in Graves' hyperthyroidism. This discovery underscores the importance of carefully weighing the risks and benefits of each treatment option for patients with Graves' hyperthyroidism.

Navigating the Treatment Landscape with Caution

This study, like a compass guiding us through the complexities of thyroid disease, highlights the importance of a cautious approach to treatment. The findings emphasize the need for a thorough discussion between patients and their physicians regarding the potential risks and benefits of different treatment options for Graves' hyperthyroidism, particularly with regard to TAO.

Dr. Camel's Conclusion

The study on TAO in Graves' hyperthyroidism underscores the importance of informed decision-making when choosing treatment options. The research highlights the potential risk associated with radioiodine treatment and emphasizes the need for careful consideration of individual risk factors and treatment goals. This research serves as a valuable resource for patients and physicians navigating the complexities of thyroid disease.

Date :
  1. Date Completed 2009-10-20
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

19723755

DOI: Digital Object Identifier

10.1210/jc.2009-0747

Related Literature

Article Analysis
・Effective treatment of hyperthyroidism
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.